For examples, miR-205 has been shown to suppress cell migration/invasion through epithelial-to-mesenchymal transition in both human prostate and breast cancer cells [23], [24], as well as to target HER3 tyrosine kinase receptor in breast cancer cells [22]. Here, NTRK1 is linked to breast cancer.